secwatch.observer — SEC 8-K summary
======================================

Issuer:     Minerva Neurosciences, Inc. (NERV)
CIK:        0001598646
Form:       8-K
Filed at:   2026-06-04T20:05:19+00:00
Accession:  0001193125-26-257379
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 3.03, 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Shareholders approve officer exculpation charter amendment; board adopts updated bylaws at annual meeting
--------------------------------------------------------------------------------

- Shareholders approved exculpation amendment to limit officer liability for monetary damages to full extent under Delaware law.
- Shareholders approved elimination of exclusive forum provision from charter.
- Board adopted amended bylaws updating advance notice, universal proxy rules, exclusive forum for Securities Act claims.
- Elected Dr. David Kupfer and Jan van Heek as directors, each term to 2029.
- Ratified Deloitte & Touche as auditor for FY 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1598646/000119312526257379/0001193125-26-257379-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1598646/000119312526257379/d57321d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-257379

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer